v3.26.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Operating activities:    
Consolidated net income $ 133,794 $ 72,063
Adjustments to reconcile consolidated net income to net cash provided by operating activities:    
Depreciation and amortization 16,292 15,615
Stock-based compensation expense 13,373 12,420
(Gain) loss on disposal of fixed assets (78) 839
Provision for doubtful accounts 0 7
Litigation payment (28,557) 0
Credit gain on available-for-sale securities (26) 0
Decrease in other assets 261 1,459
Deferred income taxes 4,023 (4)
Increase in long-term income taxes payable 57 43
Accounts receivable (61,768) (221)
Other changes in current assets and liabilities, net 2,993 21,619
Net cash provided by operating activities 80,364 123,840
Investing activities:    
Proceeds from advanced manufacturing investment credits 19,513 0
Sales or maturities of investments 3,000 0
Proceeds from sale of equipment 78 0
Additions to property, plant and equipment and internal-use software (39,700) (14,775)
Net cash used for investing activities (17,109) (14,775)
Financing activities:    
Proceeds from employee stock plans 47,087 8,935
Repurchases of Common Stock 0 (32,978)
Net cash provided by (used for) financing activities 47,087 (24,043)
Effect of foreign exchange rates on cash (10) 87
Net increase in cash and cash equivalents 110,332 85,109
Cash and cash equivalents at beginning of period 402,805 277,273
Cash and cash equivalents at end of period 513,137 362,382
Supplemental disclosure:    
Purchases of property, plant and equipment and internal-use software incurred but not yet paid $ 7,444 $ 1,862